Centre for Cardiovascular Science

Mark Nixon Research Group

Information on the research interests, projects, and members of Mark Nixon's Research Group.

Dr Mark Nixon

Postdoctoral Research Fellow


Glucocorticoid excess, particularly in adipose tissue, drives increased cardiovascular disease risk, including visceral obesity, hyperglycemia, dyslipidemia, and hypertension. Thus, efforts to reduce glucocorticoid action in adipose tissue as a treatment for cardiometabolic disease have both scientific and clinical merit. Our research is focused on the delivery mechanism through which glucocorticoids are ‘targeted’ to metabolic tissues, with the aims of not only advancing our understanding of glucocorticoid action in cardiometabolic disease, but identifying novel pathways to limit adverse glucocorticoid exposure.

For a list of up-to-date publications, please visit:

Mark Nixon's Profile Page

Willingness to take PhD Students: Yes

Research Group Members